Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study.
iPINBPA: AN INTEGRATIVE NETWORK-BASED FUNCTIONAL MODULE DISCOVERY TOOL FOR GENOME-WIDE ASSOCIATION STUDIES.
Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases.
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study.
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes.
Acute Disseminated Encephalomyelitis Following 2009 H1N1 Influenza Vaccination.
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.
Syringomyelia coexisting with guillain-barre syndrome.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
The Falls Efficacy Scale International: A Cross-Sectional Validation in People with Multiple Sclerosis.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis.
[Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
Age-effects in white matter using associated diffusion tensor imaging and magnetization transfer ratio during late childhood and early adolescence.
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
Treadmill Training or Progressive Strength Training to Improve Walking in People with Multiple Sclerosis? A Randomized Parallel Group Trial.
Estimating time-varying effects for overdispersed recurrent events data with treatment switching.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.
Pages
« first
‹ previous
…
297
298
299
300
301
302
303
304
305
…
next ›
last »